EDA Approves First NJ Angel Tax Credit for Investment in Biopharma Firm
EDA Approves First NJ Angel Tax Credit for Investment in Biopharma Firm (via NJ Tech Weekly)
Jonathan Perelman, CPA | Friedman LLP A clinical-stage biopharmaceutical firm is the first beneficiary of an investment from an angel using the New Jersey Angel Investor Tax Credit program. Approved at the New Jersey Economic Development Authority (…